Table 1.
Organ Dysfunction | |||
---|---|---|---|
n 52 (55.3) |
Yes 42 (44.7) |
p-Value | |
Demographics | |||
Age (years) | 60 (42–69) | 70 (56–78) | * 0.002 |
Gender (male) | 32 (61.5) | 24 (57.1) | 0.666 |
Pneumococcal vaccination | 1 (1.9) | 3 (7.1) | 0.213 |
Influenza vaccination | 14 (26.9) | 16 (38.1) | 0.248 |
Current smoker | 10 (19.2) | 10 (23.8) | 0.081 |
Alcohol abuse (>80 g/day) | 2 (3.8) | 2 (4.8) | 0.179 |
Prior antibiotic treatment (last month) | 22 (42.3) | 14 (33.3) | 0.374 |
Comorbid condition | |||
Diabetes mellitus | 3 (5.8) | 9 (21.4) | * 0.024 |
Chronic liver disease | 0 (0) | 1 (2.4) | 0.263 |
Heart disease | 13 (25) | 15 (35.7) | 0.259 |
Renal disease | 2 (3.8) | 5 (11.9) | 0.139 |
Neurological disease | 2 (3.8) | 5 (11.9) | 0.139 |
COPD | 3 (5.8) | 15 (35.7) | * <0.001 |
Charlson comorbidity index | 0 (0–1) | 1 (1–2) | * <0.001 |
Prognostic scales | |||
PSI (IV–V) | 6 (11.5) | 18 (42.9) | * 0.001 |
CURB65 | 1 (0–1) | 2 (1–2) | * <0.001 |
Analytical parameters on admission | |||
C-reactive protein (mg/dL) | 15.07 (6.32–25.32) | 23.64 (9.65–33.44) | * 0.046 |
Leukocytes (cell/mm3) | 12955 (8470–16800) | 15115 (10330–19710) | 0.090 |
Neutrophils (%) | 81.3 (75.7–84.8) | 87 (81.6–90.3) | * 0.001 |
Neutrophils (cell/mm3) | 10692 (6481–14203) | 13561 (7735–17597) | * 0.043 |
Lymphocytes (%) | 8.8 (6.6–12.8) | 6.8 (4.2–8.9) | * 0.005 |
Lymphocytes (cell/mm3) | 1061 (795–1518) | 854 (589–1292) | 0.057 |
Outcomes | |||
Length of stay (days) | 6 (4–8) | 7 (5–10) | 0.018 |
Clinical stability achieved | 52 (100) | 38 (90.5) | * 0.023 |
Time to clinical stability (days) | 2 (1–3) | 5 (3–7) | * <0.001 |
Treatment failure | 2 (3.8) | 6 (14.3) | 0.071 |
30-days mortality | 0 (0) | 2 (4.8) | 0.112 |
Data presented as n (%) or median (interquartile range); COPD: chronic obstructive pulmonary disease; CURB65: confusion, urea, respiratory rate, blood pressure, 65 years; PSI: pneumonia severity index. * p < 0.05.